ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Oxford Cancer Analytics Ltd

Oxford Cancer Analytics Ltd is an active company incorporated on 3 February 2020 with the registered office located in Oxford, Oxfordshire. Oxford Cancer Analytics Ltd was registered 5 years ago.
Status
Active
Active since incorporation
Company No
12437885
Private limited company
Age
5 years
Incorporated 3 February 2020
Size
Large
Did not meet the 2-out-of-3 criteria for Medium size or smaller.
Confirmation
Submitted
Dated 2 February 2025 (11 months ago)
Next confirmation dated 2 February 2026
Due by 16 February 2026 (1 month remaining)
Last change occurred 10 months ago
Accounts
Submitted
For period 1 Jan31 Dec 2024 (1 year)
Accounts type is Total Exemption Full
Next accounts for period 31 December 2025
Due by 30 September 2026 (8 months remaining)
Contact
Address
Inventa
Botley Road
Oxford
OX2 0HA
United Kingdom
Address changed on 6 Nov 2025 (2 months ago)
Previous address was Bioescalator Innovation Building Building 696, Old Road Campus, Roosevelt Drive Headington Oxford OX3 7FZ England
Telephone
Unreported
Email
Unreported
Website
Unreported
People
Officers
6
Shareholders
34
Controllers (PSC)
1
Director • Venture Capital • British • Lives in UK • Born in Jul 1981
Director • Investment Professional • British • Lives in Spain • Born in Feb 1997
Director • President & Coo, Oxford Cancer Analytics • German • Lives in England • Born in Nov 1996
Director • British • Lives in England • Born in Nov 1947
Director • Technologist • American • Lives in United States • Born in Feb 1972
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Medly Ai Limited
Jonathan Coker is a mutual person.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2021–2024)
Period Ended
31 Dec 2024
For period 31 Dec31 Dec 2024
Traded for 12 months
Cash in Bank
£8.19M
Increased by £7.44M (+989%)
Turnover
Unreported
Same as previous period
Employees
13
Increased by 2 (+18%)
Total Assets
£8.41M
Increased by £6.39M (+316%)
Total Liabilities
-£22K
Increased by £7.32K (+50%)
Net Assets
£8.39M
Increased by £6.38M (+318%)
Debt Ratio (%)
0%
Decreased by 0.46% (-64%)
Latest Activity
Registered Address Changed
2 Months Ago on 6 Nov 2025
Jian Rui Liu Resigned
2 Months Ago on 10 Oct 2025
Dr Andreas Joseph Halner Details Changed
4 Months Ago on 18 Aug 2025
Mr Jonathan Coker Appointed
6 Months Ago on 30 Jun 2025
Full Accounts Submitted
9 Months Ago on 14 Mar 2025
Notification of PSC Statement
10 Months Ago on 17 Feb 2025
Confirmation Submitted
10 Months Ago on 15 Feb 2025
Mr Andreas Joseph Halner Details Changed
10 Months Ago on 14 Feb 2025
Mr Jian Rui Liu Details Changed
10 Months Ago on 14 Feb 2025
Jian Rui Liu (PSC) Resigned
1 Year 1 Month Ago on 27 Nov 2024
Get Credit Report
Discover Oxford Cancer Analytics Ltd's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Registered office address changed from Bioescalator Innovation Building Building 696, Old Road Campus, Roosevelt Drive Headington Oxford OX3 7FZ England to Inventa Botley Road Oxford OX2 0HA on 6 November 2025
Submitted on 6 Nov 2025
Statement of capital following an allotment of shares on 17 October 2025
Submitted on 23 Oct 2025
Particulars of variation of rights attached to shares
Submitted on 20 Oct 2025
Change of share class name or designation
Submitted on 20 Oct 2025
Termination of appointment of Jian Rui Liu as a director on 10 October 2025
Submitted on 10 Oct 2025
Director's details changed for Dr Andreas Joseph Halner on 18 August 2025
Submitted on 28 Aug 2025
Statement of capital following an allotment of shares on 6 August 2025
Submitted on 22 Aug 2025
Appointment of Mr Jonathan Coker as a director on 30 June 2025
Submitted on 1 Jul 2025
Memorandum and Articles of Association
Submitted on 10 Jun 2025
Resolutions
Submitted on 10 Jun 2025
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year